Role of type 2 diabetes in determining retinal, renal, and cardiovascular outcomes in women with previous gestational diabetes mellitus

Diabetes Care

Volumn 40, Issue 1, 2017, Pages 101-108

  Retnakaran, Ravi ^a,b,c   Shah, Baiju R ^c,d,e,f  

^a MOUNT SINAI HOSPITAL   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e Institute for Clinical and Evaluative Sciences   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETOGENESIS; FEMALE; FOLLOW UP; FOOT DISEASE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; LASER COAGULATION; MAJOR CLINICAL STUDY; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; ONTARIO; PATIENT CODING; PATIENT SELECTION; PERIPHERAL VASCULAR DISEASE; PREGNANCY DIABETES MELLITUS; RETINA DISEASE; RETINOPATHY; RISK; VITRECTOMY; CARDIOVASCULAR DISEASES; CASE CONTROL STUDY; DIABETES MELLITUS, TYPE 2; EVALUATION STUDY; KIDNEY DISEASES; MICROVASCULATURE; PATHOPHYSIOLOGY; PREGNANCY; PROPORTIONAL HAZARDS MODEL; PUERPERIUM; RETINAL DISEASES; RISK FACTOR; TIME FACTOR;

ADULT; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; HUMANS; KIDNEY DISEASES; MICROVESSELS; ONTARIO; POSTPARTUM PERIOD; PREGNANCY; PROPORTIONAL HAZARDS MODELS; RETINAL DISEASES; RISK FACTORS; TIME FACTORS;

EID: 85008195159     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-1400     Document Type: Article

References (34)

1. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis. Lancet 2009;373:1773-1779
2. Retnakaran R. Glucose tolerance status in pregnancy: A window to the future risk of diabetes and cardiovascular disease in young women. Curr Diabetes Rev 2009;5:239-244
3. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005;115:485-491
4. Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B. Beta-cell function declines within the first year postpartum in women with recent glucose intolerance in pregnancy. Diabetes Care 2010;33:1798-1804
5. Retnakaran R, Qi Y, Ye C, et al. Hepatic insulin resistance is an early determinant of declining b-cell function in the first year postpartumafter glucose intolerance in pregnancy. Diabetes Care 2011;34:2431-2434
6. Xiang AH, Kjos SL, Takayanagi M, Trigo E, Buchanan TA. Detailed physiological characterization of the development of type 2 diabetes in Hispanic women with prior gestational diabetes mellitus. Diabetes 2010;59:2625-2630
7. Xiang AH, Takayanagi M, Black MH, et al. Longitudinal changes in insulin sensitivity and beta cell function between women with and without a history of gestational diabetes mellitus. Diabetologia 2013;56:2753-2760
8. Kramer CK, Swaminathan B, Hanley AJ, et al. Each degree of glucose intolerance in pregnancy predicts distinct trajectories of b-cell function, insulin sensitivity, and glycemia in the first 3 years postpartum. Diabetes Care 2014;37: 3262-3269
9. Marcinkevage JA, Narayan KM. Gestational diabetes mellitus: taking it to heart. Prim Care Diabetes 2011;5:81-88
10. Sullivan SD, Umans JG, Ratner R. Gestational diabetes: implications for cardiovascular health. Curr Diab Rep 2012;12:43-52
11. Brewster S, Zinman B, Retnakaran R, Floras JS. Cardiometabolic consequences of gestational dysglycemia. J Am Coll Cardiol 2013;62: 677-684
12. Archambault C, Arel R, Filion KB. Gestational diabetes and risk of cardiovascular disease: A scoping review. Open Med 2014;8: e1-e9
13. Harreiter J, Dovjak G, Kautzky-Willer A. Gestational diabetes mellitus and cardiovascular risk after pregnancy. Womens Health (Lond) 2014;10:91-108
14. Carr DB, Utzschneider KM, Hull RL, et al. Gestational diabetes mellitus increases the risk of cardiovascular disease in women with a family history of type 2 diabetes. Diabetes Care 2006;29:2078-2083
15. Shah BR, Retnakaran R, Booth GL. Increased risk of cardiovascular disease in young women following gestational diabetes mellitus. Diabetes Care 2008;31:1668-1669
16. Retnakaran R, Shah BR. Mild glucose intolerance in pregnancy and risk of cardiovascular disease: A population-based cohort study. CMAJ 2009;181:371-376
17. Fadl H, Magnuson A, Ostlund I, Montgomery S, Hanson U, Schwarcz E. Gestational diabetesmellitus and later cardiovascular disease: A Swedish population based case-control study. BJOG 2014;121:1530-1536
18. Hux JE, Ivis F, Flintoft V, Bica A. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002;25:512-516
19. Kralji B. Measuring "rurality" for purposes of health-care planning: an empirical measure for Ontario. Ont Med Rev 2000;67:33-52
20. Shah BR, Lipscombe LL, Feig DS, Lowe JM. Missed opportunities for type 2 diabetes testing following gestational diabetes: A populationbased cohort study. BJOG 2011;118:1484-1490
21. Retnakaran R, Qi Y, SermerM, Connelly PW, Hanley AJ, Zinman B. Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes. Diabetes Care 2008;31:2026-2031
22. Verma A, Boney CM, Tucker R, Vohr BR. Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J Clin Endocrinol Metab 2002;87:3227-3235
23. Lauenborg J, Mathiesen E, Hansen T, et al. The prevalence of the metabolic syndrome in a danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population. J Clin Endocrinol Metab 2005;90:4004-4010
24. Retnakaran R, Qi Y, Connelly PW, SermerM, Zinman B, Hanley AJ. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab 2010;95:670-677
25. Xu Y, Shen S, Sun L, Yang H, Jin B, Cao X. Metabolic syndrome risk after gestational diabetes: A systematic review and meta-analysis. PLoS One 2014;9:e87863
26. Tobias DK, Hu FB, Forman JP, Chavarro J, Zhang C. Increased risk of hypertension after gestational diabetes mellitus: findings from a large prospective cohort study. Diabetes Care 2011;34:1582-1584
27. Meyers-Seifer CH, Vohr BR. Lipid levels in former gestational diabetic mothers. Diabetes Care 1996;19:1351-1356
28. Retnakaran R, Qi Y, Connelly PW, SermerM, Hanley AJ, Zinman B. The graded relationship between glucose tolerance status in pregnancy and postpartum levels of low-density-lipoprotein cholesterol and apolipoprotein B in young women: implications for future cardiovascular risk. J Clin Endocrinol Metab 2010;95:4345-4353
29. Retnakaran R, Qi Y, Connelly PW, SermerM, Hanley AJ, Zinman B. Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta cell dysfunction and fasting glycaemia. Diabetologia 2010;53:268-276
30. Qiu C, Rudra C, Austin MA, Williams MA. Association of gestational diabetes mellitus and low-density lipoprotein (LDL) particle size. Physiol Res 2007;56:571-578
31. Rizzo M, Berneis K, Altinova AE, et al. Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. Diabet Med 2008;25:1406-1411
32. Gunderson EP, Quesenberry CP Jr, Jacobs DR Jr, Feng J, Lewis CE, Sidney S. Longitudinal study of prepregnancy cardiometabolic risk factors and subsequent risk of gestational diabetes mellitus: The CARDIA study. Am J Epidemiol 2010;172:1131-1143
33. Hedderson MM, Darbinian JA, Quesenberry CP, Ferrara A. Pregravid cardiometabolic risk profile and risk for gestational diabetes mellitus. Am J Obstet Gynecol 2011;205:55.e1-55.e7
34. Wen SW, Xie RH, Tan H, Walker MC, Smith GN, Retnakaran R. Preeclampsia and gestational diabetes mellitus: pre-conception origins? Med Hypotheses 2012;79:120-125